Professor Dra. Laura Lechuga will receive the XVIII Burdinola Research Award -The studies that she carries out on the subject of the award in relation to nanodiagnosis, regenerative medicine and personalized therapy, in the field of Nanomedicine, are excellent. -Professor Laura Lechuga received her doctorate in Chemistry from the Complutense University of Madrid (Spain) in 1992. She is Professor of the Higher Council for Scientific Research (CSIC) and Head of the Group of Nanobiosensors and Bioanalytical Applications of the Catalan Institute of Nanoscience and Nanotechnology ( ICN2) in Barcelona (Spain) and at the Center for Online Biomedical Research (CIBER-BBN). She has been Adjunct Professor at the Artic University of Norway (2012-2016) and Distinguished Visiting Professor at the University of Campinas (Brazil) (2013-2017).

Dr. Laura Lechuga has been recognized by the jury of the XVIII Burdinola Research Award as the recipient of this award, which in this edition has wanted to distinguish the most outstanding work in the Nanomedicine field: nanodiagnosis, regenerative medicine and personalized therapy. At the jury meeting, her leadership and her pioneering attitude, transfer activity and international visibility were especially highlighted. 

Dr. Lechuga's laboratory, created in 1998, a pioneer in the area of ​​Nanodiagnosis, is today a world reference in the field of nanobiosensor devices based on photonic principles. Dr. Lechuga stands out for combining both the basic science aspect and a sophisticated technological development of devices, always with her own ideas and designs, which have been implemented in pioneering technologies at an international level with a notable interdisciplinarity in physics, microtechnologies, photonics, biology and medicine and demonstrating its direct applicability in the diagnosis of diseases (mainly cancer and infectious diseases)

 Dr. Lechuga directs at ICN2 the research group "Nanobiosensors and Bioanalytical Applications" oriented towards Nanomedicine and which has more than 20 members. She is also a Research Professor at the CSIC and is linked to the CIBER-BBN (Biomaterials, Bioengineering and Nanomedicine) of the Carlos III Health Institute. Her research area focuses on Nanomedicine, Nanodiagnosis and the technological development of Nanobiosensors and their integration in portable platforms such as “Point-of Care” (POC), as well as their application in decentralized clinical diagnosis.

 In the field of Nanodiagnosis, her most important scientific contributions focus on the development of highly sensitive and miniaturizable nanoplasmonic and nanoplasmonic biosensors, developed with her own ideas and technology, as well as on the technological transfer of her results. Her work has been an international pioneer in photonic biosensor devices such as the Mach-Zehnder interferometer and bimodal interferometric guides, the magnetoplasmonic biosensor or the waveguide microlever biosensor. His great experience in the biofunctionalization of sensor surfaces and in the application of the devices, has allowed the use of them for the evaluation of real problems such as the early diagnosis of diseases such as cancer or infectious diseases, directly in human samples, in a fast and accurate. One of the main achievements of his work is the development of functional platforms type "lab-on-a-chip", with the integration of biosensors, microfluidics, electronics, hardware and software in a single platform, in a device that It can be used outside the laboratory environment (“point-of-care” device).

 Her high international impact is reflected in his impressive CV, where it should be noted that he has published more than 270 research papers (h-index = 51 and more than 9900 citations, Google Scholar) and has given more than 365 invited lectures around the world. , including the most prestigious conferences in its field. One of the main aspects to highlight of his scientific career is his translational vocation, with an important and successful work of technology transfer, including the management of 8 patent families, the creation of two spin-off companies: SENSIA, SL (2004) and BIOD, SL (2010), the transfer of various patents and collaboration with numerous companies of national relevance, which began very early with a successful collaboration during their Doctoral Thesis stage (1990) with the company Tabacalera, SA.


Evaluation of the candidatures

 Throughout these years, another of the hallmarks of the award has been the high scientific and business level of the members of the jury.

 In this seventeenth edition, seven experts have evaluated the different candidacies and chosen, based on their merits, the winner among all of them. The jury has been chaired by Doctor Joseba Pineda, dean of the UPV / EHU Faculty of Medicine and Nursing, being the secretary the Director of the Euskoiker University-Business Foundation, Doctor Alfonso Hernández. The committee has also had five prestigious members: Dr. Maria Ángeles Muñoz, Dr. Maria José Alonso, Dr. Arkaitz Carracedo, Dr. Josep Samitier and Don Mikel Martínez, General Director of Burdinola, the latter with voice but without vote.

 In its decision, the jury also wanted to highlight the high level of quality of the applications presented in this eighteenth call for the Burdinola Research Award


Support research

 An activity in direct contact with the research teams and a special sensitivity to the social environment, made Burdinola germinate the idea of ​​creating an award that, precisely, would contribute to the recognition, appreciation and encouragement of the scientific community. This purpose materialized in 1994 with the launch of the first Burdinola Research Award. Since then, the list of winners has grown with great names in Spanish scientific activity.

» back